Adrian Kee Keong Teo
Overview
Explore the profile of Adrian Kee Keong Teo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
836
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Ching C, Iich E, Teo A
Handb Exp Pharmacol
. 2023 Jun;
281:301-332.
PMID: 37306817
The long-standing goals in diabetes research are to improve β-cell survival, functionality and increase β-cell mass. Current strategies to manage diabetes progression are still not ideal for sustained maintenance of...
12.
Chan J, Neo C, Ghosh S, Choi H, Lim S, Tai E, et al.
Cell Death Dis
. 2023 May;
14(5):302.
PMID: 37137894
Renal defects in maturity onset diabetes of the young 3 (MODY3) patients and Hnf1a mice suggest an involvement of HNF1A in kidney development and/or its function. Although numerous studies have...
13.
Tay K, Wu K, Chioh F, Autio M, Pek N, Narmada B, et al.
Atherosclerosis
. 2022 Nov;
362:11-22.
PMID: 36435092
Background And Aims: Single nucleotide polymorphism rs6903956 has been identified as one of the genetic risk factors for coronary artery disease (CAD). However, rs6903956 lies in a non-coding locus on...
14.
Lim L, Ding S, Muthukumaran P, Teoh S, Koh Y, Teo A
Acta Biomater
. 2022 Nov;
157:49-66.
PMID: 36427686
Diabetes mellitus is a global disease requiring long-term treatment and monitoring. At present, pancreas or islet transplantation is the only reliable treatment for achieving stable euglycemia in Type I diabetes...
15.
Lim L, Ching C, Kong D, Chan S, Teo A
Methods Cell Biol
. 2022 Jul;
170:127-146.
PMID: 35811096
Diabetes is a major healthcare burden globally, affecting over 463 million people today, according to the International Diabetes Federation. The most common types of diabetes are Type I diabetes (T1D)...
16.
Pistollato F, Bal-Price A, Coecke S, Parvatam S, Pamies D, Czysz K, et al.
Reprod Toxicol
. 2022 Jun;
112:36-50.
PMID: 35697279
The advent of the technology to isolate or generate human pluripotent stem cells provided the potential to develop a wide range of human models that could enhance understanding of mechanisms...
17.
Lau H, Gan S, Lickert H, Shapiro A, Lee K, Teo A
Med
. 2022 May;
2(10):1138-1162.
PMID: 35590204
The discovery of insulin a century ago changed the lives of millions of individuals suffering from diabetes, paving the way for long-term survival. While the availability of recombinant insulin for...
18.
Kong D, Yu H, Sim X, White K, Tai E, Wenk M, et al.
Front Digit Health
. 2022 May;
4:845405.
PMID: 35585913
In the past one or two decades, countries across the world have successively implemented different precision medicine (PM) programs, and also cooperated to implement international PM programs. We are now...
19.
Tan W, Bok C, Ng N, Teo A
Methods Mol Biol
. 2022 May;
2429:215-232.
PMID: 35507164
Chromatin immunoprecipitation (ChIP) is a technique that has been widely used to interrogate DNA-protein interactions in cells. In recent years, human pluripotent stem cell (hPSC)-derived 3D organoids have emerged as...
20.
Tan L, Chen J, Lim L, Teo A
Cell Prolif
. 2022 Apr;
55(8):e13232.
PMID: 35474596
The unlimited proliferative capacity of human pluripotent stem cells (hPSCs) fortifies it as one of the most attractive sources for cell therapy application in diabetes. In the past two decades,...